Last Updated: July 21, 2026

Suppliers and packagers for ECOZA


✉ Email this page to a colleague

« Back to Dashboard


ECOZA

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Resilia Pharms ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA AUTHORIZED GENERIC Trifluent Pharma, LLC 73352-100-70 1 CANISTER in 1 CARTON (73352-100-70) / 70 g in 1 CANISTER 2025-09-13
Resilia Pharms ECOZA econazole nitrate AEROSOL, FOAM;TOPICAL 205175 NDA Resilia Pharmaceuticals, Inc. 81811-100-70 1 CANISTER in 1 CARTON (81811-100-70) / 70 g in 1 CANISTER 2023-12-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

ECOZA (Econazole) Suppliers: Who Manufactures and Supplies the Drug, Ingredients, and Finished Dosage for Distribution

Last updated: May 27, 2026

ECOZA is a brand of econazole (topical antifungal). Supplier coverage depends on the specific strength and dosage form that matches the US-listed product under the ECOZA brand. Without the exact marketed form (eg, cream vs. other topical presentation) and the target geography, supplier identification cannot be completed in a way that is both accurate and legally useful.

Which companies supply ECOZA (econazole) to pharmacies and wholesalers?

Featured snippet answer: ECOZA’s commercial supply is handled by the firm that holds the US label/marketing authorization for the specific ECOZA dosage form, with manufacturing performed by the label’s contract manufacturers and/or affiliated sites. To name the correct manufacturers and contract sites, the exact ECOZA product listing and labeler for the marketed strength and dosage form must be used.

How ECOZA supply chains typically map for topical antifungals

  • Labeler/holder: the party marketing the branded product under the NDC
  • Contract manufacturers: facilities that produce and package the finished topical drug
  • API suppliers: upstream suppliers of econazole or econazole-grade intermediates
  • Warehousing and distribution: third-party logistics and specialty distributors handling replenishment

What is the ECOZA supplier list from the Orange Book and FDA labeling?

Featured snippet answer: The Orange Book identifies approved drug products for which patents and exclusivity are listed. FDA labeling sources identify the applicant/labeler and often list manufacturers and packagers tied to the application. A complete supplier list requires tying the specific ECOZA NDC to its FDA listing.

Orange Book vs. FDA labeling: which identifies suppliers

  • Orange Book: product identification and patent/exclusivity record, not a full bill of materials supplier map
  • FDA label (package insert): the clearest source for finished dosage manufacturing and repackaging entities
  • NDC directory: labeler mapping for distribution responsibility

Who manufactures ECOZA cream and who contracts for packaging?

Featured snippet answer: ECOZA finished dosage manufacturing and packaging are performed by the companies listed as manufacturing/packaging locations on the product label tied to the ECOZA NDC for the exact strength and dosage form.

Typical manufacturer types in ECOZA supply

  • Finished dosage manufacturers (topical creams and semisolids)
  • Fill-finish and packaging sites (tubes, jars, and cartons)
  • Repackagers (if the labeler uses multiple packaging locations)

Which suppliers provide econazole API and intermediates used in ECOZA?

Featured snippet answer: Econazole API supply is typically sourced from specialized API manufacturers and intermediate producers. A verified supplier list requires mapping the econazole API used in the specific branded ECOZA product to its labeled manufacturing process and known raw material sourcing, which is not recoverable from brand name alone.

API supply chain for econazole topical products

  • Econazole synthesis (active ingredient)
  • Econazole-grade intermediates (key steps before API isolation)
  • Conformity to pharmacopeial and QC specs for topical formulation

What contract manufacturing risks matter for ECOZA supply continuity?

Featured snippet answer: Supply continuity risk concentrates in (1) single-site manufacturing, (2) semisolid formulation expertise, and (3) packaging capacity constraints for tubes and secondary packaging.

Common bottlenecks in topical antifungal production

  • semisolid consistency and stability under accelerated conditions
  • viscosity and particle distribution control
  • tube filling, seal integrity, and line clearance scheduling

How does ECOZA compare with other econazole topical brands on supplier footprint?

Featured snippet answer: Comparisons are possible once the specific product NDC and strength are fixed. Different econazole-branded products can have different labelers and contract manufacturers even if the active ingredient is the same.

What to compare in supplier footprint analysis

  • labeler identity (US marketing responsibility)
  • manufacturing site list
  • packaging site list
  • any repackager entities

Key Takeaways

  • ECOZA supplier identification must be tied to the exact ECOZA marketed dosage form and strength using its US NDC, because labeler, finished dosage manufacturer, and packaging site can change by presentation.
  • A legally useful “who supplies ECOZA” list is built from FDA product listing/labeling tied to the specific NDC, then cross-walked to contract manufacturing and packaging locations.
  • Econazole API supplier mapping cannot be completed from the brand name alone; it requires NDC-specific process and product linkage.

FAQs

  1. What does the ECOZA package insert list as the manufacturer and packager?
  2. How do I identify the labeler for ECOZA using its NDC?
  3. Are ECOZA manufacturers the same for every strength and dosage form?
  4. Which documents show ECOZA contract manufacturing sites in the US?
  5. Do topical econazole generics use the same API suppliers as branded ECOZA?

References

  1. FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (n.d.). FDA.
  2. US FDA Drug Labeling (DailyMed). (n.d.). National Library of Medicine.
  3. FDA NDC Directory. (n.d.). FDA.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.